Your daily source for AI news, tools reviews, and practical guides to artificial intelligence
Anthropic’s acquisition of biotech startup Coefficient Bio for $400 million marks a significant expansion of AI applications into life sciences, aiming to revolutionize drug development by leveraging artificial intelligence.
Anthropic’s $400 million acquisition of biotech startup Coefficient Bio marks a strategic move into life sciences, aiming to leverage AI to transform drug development by reducing costs, time, and uncertainty.
Agentic AI, capable of autonomously managing complex marketing tasks, is poised to revolutionize life sciences marketing, potentially generating $450 billion globally by 2028 through enhanced revenue and cost efficiencies.